History of Wintac Ltd.
YEAR EVENTS 1986 - The Comp. was originally registered as Recon Pharma, a partnership firm in year by following partners namely, Mr. S. Jayaprakash Mady, Ms. Meenakshi Mady, Ms. Ratnakala Mady & Ms. Roopa Nagaraj with the main objective of manufacturing and marketing high quality formulations.
1990 - Recon Pharma Private Limited was incorporated under the Act to take over the business of partnership firm Recon Pharma.
1993 - The Comp. changed its name to Recon Private Limited on 1st March. The Comp. subsequently got converted into a Public Limited Comp. on 3rd March & received fresh Certificate of Incorporation on 5th March.
- The Comp. implemented the backward integration to manufacture bulk drug viz., Pefloxacin Mesylate mainly for captive consumption of Pharma division.
- The Comp. has received 'Quality Excellence Award' for its formulation facility, for 1992, from Indian Drug Manufacturers Association.
- The Comp. has increased its product range resulting in substantial increase in business by acquiring certain Trade Marks.
- The Comp. has an exclusive Research and Development Centre at Bangalore.
1994 - Recon launch of ROLOX was indeed the most talked about introduction in the Pharmaceutical Industry.
- Recon launched yet another products under the brand name Rhizin. - Recon has launched a blue green algae, Spirulina under the brand name RECOLINA.
- The Comp. entered the Capital Market in December with a public issue of 10 lakh Equity shares of Rs. 10/- each at a premium of Rs.90 per share.
1995 - The Comp. has entered into a strategic alliance with Tech India Ventures Inc, Lake Forest, Illinois, USA.
- Recon has recently set up a Joint Venture Comp. in Tanzania, 'Recon [Tanzanias] Limited'.
- Recon is in the process of setting up a wholly owned subsidiary at South Africa in order to boost its exports.
- Recon Chemicals Private Limited has become a subsidiary of the Comp. with effect from 20th May. Blumen Floriculture [Indias] Private Limited, a Comp. carrying on floriculture business, by virtue of being a subsidiary of Recon Chemicals Pvt. limited has also become a subsidiary of Company.
1996 - The Comp. is proposed to set up projects at Indonesia & Ghana in collaboration with our counterparts in the respective countries with Equity participation upto 51% in the Joint Venture Company.
1997 - Recon Agrotech Limited became the subsidiary of Comp. with effect from 1st August.
- Recon Limited, a Bangalore-based pharmaceutical company, is setting up a joint venture Comp. in Indonesia.
1998 - Recon has successfully concluded on agreement with National Biochemicals Corporation, Cleveland, Ohio USA for substantial quantities of certain drugs.
- Recon is confident of obtaining ISO 9001 certification by September.
1999 - The Formulation Division saw the successful launch of NOVOSPAR, a Sparfloxacin formulation, ILIS - a formulation of Lisinopril, LANS-MD a brand extension of our existing brand LANS-OD.
- The Comp. had also embarked on a collaborative project with the National Chemicals Laboratory [NCLs], Pune, to develop a new anti-HIV drug.
2000 - The Rs 478-crore Zydus Cadila Healthcare has signed a memorandum of understanding with Bangalore-based Recon Ltd to acquire its formulations business for Rs 27 crore.
- The Comp. have signed a MoU to transfer the trademarks and know-how related to the formulation business of Comp. to a joint venture Comp. to be promoted by Cadila Healthcare Ltd. & Recon Ltd.
